Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.83)
# 447
Out of 4,421 analysts
126
Total ratings
55.4%
Success rate
33.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Maintained: Buy | $110 | $35.09 | +213.48% | 10 | Jun 5, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 → $25 | $8.33 | +200.12% | 19 | Jun 3, 2026 | |
| JBIO Jade Biosciences | Rated: Buy | $45 → $55 | $16.82 | +226.99% | 5 | Jun 1, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $15.56 | $8.26 | +88.36% | 12 | May 18, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Buy | $185 | $60.98 | +203.38% | 17 | May 11, 2026 | |
| PRME Prime Medicine | Reiterated: Hold | n/a | $3.23 | - | 15 | May 8, 2026 | |
| ADAG Adagene | Reiterated: Buy | $7 | $3.94 | +77.66% | 18 | Apr 7, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $16.46 | +3.28% | 3 | Feb 27, 2026 | |
| BCAB BioAtla | Reiterated: Hold | n/a | $3.66 | - | 15 | Aug 11, 2025 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.04 | - | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.14 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.00 → $35.00 | $26.68 | n/a | 3 | Apr 3, 2023 |
Vera Therapeutics
Jun 5, 2026
Maintained: Buy
Price Target: $110
Current: $35.09
Upside: +213.48%
Solid Biosciences
Jun 3, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $8.33
Upside: +200.12%
Jade Biosciences
Jun 1, 2026
Rated: Buy
Price Target: $45 → $55
Current: $16.82
Upside: +226.99%
Satellos Bioscience Inc.
May 18, 2026
Reiterated: Buy
Price Target: $15.56
Current: $8.26
Upside: +88.36%
Nektar Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $185
Current: $60.98
Upside: +203.38%
Prime Medicine
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.23
Upside: -
Adagene
Apr 7, 2026
Reiterated: Buy
Price Target: $7
Current: $3.94
Upside: +77.66%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $16.46
Upside: +3.28%
BioAtla
Aug 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.66
Upside: -
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.04
Upside: -
Jun 21, 2024
Maintained: Buy
Price Target: n/a
Current: $24.14
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $27.00 → $35.00
Current: $26.68
Upside: n/a